Author

Manuel L. R. Tjin‐A‐Ton

Observed names: M L R Tjin-A-Ton, M L R Tjin-A-ton, M. L. R. Tjin-a-Ton, M. L. Tjin-A-ton, M. Tjin-A-Ton, M. Tjin-A-ton, M.L.R. Tjin-A-Ton, Manuel L. R. Tjin-A-Ton, Manuel L. Tjin-A-Ton, Manuel L.R. Tjin-A-Ton, Manuel Lucien Roy Tjin-A-Ton, Manuel Tjin-A-Ton, Manuel Tjin-a-Ton, Manuel Tjin‐A‐Ton

Observed institutions: Radboud University Nijmegen, Utrecht University, Maastricht University Medical Centre, Radboud University Medical Center, University Medical Center Utrecht, Maastricht University, Ziekenhuis Rivierenland

OpenAlex ID: A5086589378

Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients

2019 · Sophie Kurk, Petra Peeters, et al. · Journal of Cachexia Sarcopenia and Muscle · 106

PDF

Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative

2017 · R. R. J. Coebergh van den Braak, L. B. van Rijssen, et al. · Acta Oncologica · 86

PDF

Trajectories of health-related quality of life and psychological distress in patients with colorectal cancer: A population-based study

2021 · Seyed M. Qaderi, Joost A.G. van der Heijden, et al. · European Journal of Cancer · 53

PDF

The Prospective Dutch Colorectal Cancer (PLCRC) cohort: real-world data facilitating research and clinical care

2021 · Jeroen W. G. Derksen, Geraldine R. Vink, et al. · Scientific Reports · 40

PDF

Prospective cohort study of patients with advanced cancer and their relatives on the experienced quality of care and life (eQuiPe study): a study protocol

2020 · Janneke van Roij, Myrte Zijlstra, et al. · BMC Palliative Care · 33

PDF

Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial

2019 · Sophie A. Kurk, Petra H. M. Peeters, et al. · Cancer Medicine · 33

PDF

Hypertension, Stroke, and Coronary Heart Disease in Relatives of Patients With Subarachnoid Hemorrhage

1996 · J.E.C. Bromberg, G.J.E. Rinkel, et al. · Stroke · 30

Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era

2020 · G. Emerens Wensink, Marloes A. G. Elferink, et al. · British Journal of Cancer · 24

PDF

Transanal total mesorectal excision and low anterior resection syndrome

2021 · J A G van der Heijden, S M Qaderi, et al. · British journal of surgery · 23

PDF

Phase I evaluation of AZD2171, a highly potent, selective VEGFR signaling inhibitor, in combination with gefitinib, in patients with advanced tumors

2006 · H. Van Cruijsen, E. E. Voest, et al. · Journal of Clinical Oncology · 15

Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)

2022 · Patricia A.H. Hamers, Geraldine R. Vink, et al. · Clinical Colorectal Cancer · 14

PDF

Physical Activity Is Associated with Improved Overall Survival among Patients with Metastatic Colorectal Cancer

2022 · Karel C. Smit, Jeroen W. G. Derksen, et al. · Cancers · 14

PDF

Quality of myositis case reports open to improvement

2004 · Janneke van de Vlekkert, Manuel L. R. Tjin‐A‐Ton, et al. · Arthritis Care & Research · 13

A phase I study of IMC-11F8, a fully human anti-epidermal growth factor receptor (EGFR) IgG1 monoclonal antibody in patients with solid tumors. Interim results

2006 · B. Kuenen, E. Witteveen, et al. · Journal of Clinical Oncology · 8

Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study

2025 · Carmen Rubio-Alarcón, Andrew Georgiadis, et al. · British journal of surgery · 6

Impact of skeletal muscle index (SMI) loss during palliative systemic treatment (Tx) on time to progression and overall survival (OS) in metastatic colorectal cancer (mCRC) patients.

2017 · Sophie Kurk, Petra H.M. Peeters, et al. · Journal of Clinical Oncology · 6

Impact of sarcopenia on dose limiting toxicities in metastatic colorectal cancer patients (mCRC pts) receiving palliative systemic treatment

2017 · S. Kurk, P. Peeters, et al. · Annals of Oncology · 4

PDF

[Skin eruptions as an adverse reaction to epidermal growth-factor receptor inhibitors].

2007 · M L R Tjin-A-ton, C van Montfrans, et al. · PubMed · 3

Abstract CT067: The Prospective Dutch ColoRectal Cancer Cohort (PLCRC): a prospective nationwide observational cohort study providing the infrastructure for registry based trials

2017 · Geraldine Vink, Robert Coebergh van den Braak, et al. · Cancer Research

Microsatellite Instability Screening in Young Colorectal Cancer Patients in the Mid-Netherlands in the Period 1999-2008

2011 · Koen Kessels, Nicolette L. de Groot, et al. · Gastroenterology

A phase I study of IMC-11F8, a recombinant human anti-epidermal growth factor receptor (EGFR) IgG1 monoclonal antibody in patients with solid tumors

2007 · Bart C. Kuenen, Petronella O. Witteveen, et al. · Molecular Cancer Therapeutics

8116 POSTER Multidisciplinary management of toxicities EGFR-inhibitors

2007 · J.J. Koldenhof, M.L.R. Tjin-A-Ton, et al. · European Journal of Cancer Supplements

Quality of evidence in case reports inadequate : a systematic review in myositis

2002 · J. van de Vlekkert, M L R Tjin-A-Ton, et al. · Neuromuscular Disorders

Unexpected overdose with diltiazem: value of toxicological screening.

2001 · P W Kamphuisen, M Karreman, et al. · PubMed

Works count: 24

Citation count: 511

H-index: 13

I10-index: 13